In 2014, MPEG LA entered into a collaboration to develop and license therapeutic oligonucleotide conjugate t​echnology. This lead to Increscent Therapeutics™ -- a versatile platform for single ligand-multiple payload delivery. For information on the technology and partnering/licensing opportunities:Increscent™ PresentationIncrescent™ Poster​Increscent™ Data Package​​​​